Description
MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| CISA-ADPADP (enrichment) | 3.1 | Medium6.1 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
| NVDNVD · Modified | 3.1 | Medium6.1 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
- EPSS (exploitation in 30 days)
- 0.57% · top 53% of all CVEs (7 Nov 2026)
- CISA SSVC
- Exploitation: none · Automatable: no · Technical impact: partial
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: Medium 6.1.
Weakness
Affected products
de.ipb-halle:molecularfaces
- affected < 0.3.0
Affected packages
From reviewed advisories of the GitHub Advisory Database.
- Mavende.ipb-halle:molecularfacesGHSA-2pwh-52h7-7j84 (opens in a new tab)
References (3)
- https://github.com/ipb-halle/MolecularFaces/security/advisories/GHSA-2pwh-52h7-7j84 (opens in a new tab)vendor-advisoryx_transferred
- https://github.com/advisories/GHSA-2pwh-52h7-7j84 (opens in a new tab)vendor-advisorythird-party-advisoryx_transferred
- https://vulncheck.com/advisories/vc-advisory-GHSA-2pwh-52h7-7j84 (opens in a new tab)third-party-advisoryx_transferred
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisory GHSA-2pwh-52h7-7j84 (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://trackcve.app/cve/CVE-2024-0758)Record last updated .